Ophthalmics Collaboration and Licensing Deals 2019-2026

Description

The definitive benchmark for ophthalmics dealmaking

Ophthalmics partnering spans a range of chronic and vision-threatening conditions, with deal structures reflecting specialised delivery methods, targeted therapies, and distinct clinical development pathways.

This report provides a comprehensive and structured analysis of 374 ophthalmics collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how ophthalmics deals are structured in practice, allowing you to:

Benchmark comparable transactions with confidence
Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
Define realistic market parameters
Clear insight into how deal terms vary by stage, asset type, and partner profile
Support valuation and structuring decisions with evidence
Ground internal discussions in real transaction data rather than assumptions
Understand how leading companies approach dealmaking
Visibility into partner behaviour and recurring deal structures across a specialised and innovation-driven therapeutic landscape
Full visibility into deal structure and execution
Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

Rights granted and retained
Development and commercialization responsibilities
Financial structures and payment triggers
Key contractual provisions and protections
This level of transparency is critical to understanding how value, risk, and control are allocated within ophthalmics partnerships, particularly in areas requiring specialised delivery and long-term treatment approaches.
Designed for real-world BD and strategy use

The report is widely used to:

Structure and benchmark live transactions
Prepare for negotiations with well-defined market context
Evaluate partnership opportunities and counterparties
Support internal strategy with robust, defensible data
What's included
374 ophthalmics collaboration and licensing deals
Financial terms, including upfronts, milestones, and royalties where disclosed
Fully searchable deal directory (by company, therapy, and technology)
Direct access to SEC-filed agreements and source documents
Analysis of deal trends, key transactions, and active dealmakers
A trusted, evidence-based reference for ophthalmics dealmaking
Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how ophthalmics partnerships are structured, negotiated, and valued.

Product Code: CP2219

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in ophthalmics dealmaking

2.1. Introduction
2.2. Ophthalmics partnering over the years
2.3. Ophthalmics partnering by deal type
2.4. Ophthalmics partnering by industry sector
2.5. Ophthalmics partnering by stage of development
2.6. Ophthalmics partnering by technology type
2.7. Ophthalmics partnering by therapeutic indication

Chapter 3 - Financial deal terms for ophthalmics partnering

3.1. Introduction
3.2. Disclosed financials terms for ophthalmics partnering
3.3. Ophthalmics partnering headline values
3.4. Ophthalmics deal upfront payments
3.5. Ophthalmics deal milestone payments
3.6. Ophthalmics royalty rates

Chapter 4 - Leading ophthalmics deals and dealmakers

4.1. Introduction
4.2. Most active in ophthalmics partnering
4.3. List of most active dealmakers in ophthalmics
4.4. Top ophthalmics deals by value

Chapter 5 - Ophthalmics contract document directory

5.1. Introduction
5.2. Ophthalmics partnering deals where contract document available

Chapter 6 - Ophthalmics dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by ophthalmics therapeutic target
Deal directory
Deal directory - Ophthalmics deals by company A-Z
Deal directory - Ophthalmics deals by technology type
Deal type definitions
About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Ophthalmics partnering since 2019
Figure 2: Ophthalmics partnering by deal type since 2019
Figure 3: Ophthalmics partnering by industry sector since 2019
Figure 4: Ophthalmics partnering by stage of development since 2019
Figure 5: Ophthalmics partnering by technology type since 2019
Figure 6: Ophthalmics partnering by indication since 2019
Figure 7: Ophthalmics deals with a headline value
Figure 8: Ophthalmics deals with upfront payment values
Figure 9: Ophthalmics deals with milestone payment
Figure 10: Ophthalmics deals with royalty rates
Figure 11: Active ophthalmics dealmaking activity since 2019
Figure 12: Top ophthalmics deals by value since 2019